Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials

Immunoglobulin D (IgD) myeloma is a subtype often considered to have adverse features and inferior survival, but there is a paucity of data from large clinical studies. We compare the clinical characteristics and outcomes of patients with IgD myeloma from UK phase 3 myeloma trials analyzed in 2 grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbuduwe, Charles, Iqbal, Gulnaz, Cairns, David, Menzies, Tom, Dunn, Janet, Gregory, Walter, Kaiser, Martin, Owen, Roger, Pawlyn, Charlotte, Child, J. Anthony, Davies, Faith, Morgan, Gareth J., Jackson, Graham H., Drayson, Mark T., Basu, Supratik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631630/
https://www.ncbi.nlm.nih.gov/pubmed/35790108
http://dx.doi.org/10.1182/bloodadvances.2022007608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631630/
https://www.ncbi.nlm.nih.gov/pubmed/35790108
http://dx.doi.org/10.1182/bloodadvances.2022007608

Ejemplares similares